Evidence map›Paper›PMID 36473464›Full record

ArticleInorganic chemistry2022

Enriching Chemical Space of Bioactive Scaffolds by New Ring Systems: Benzazocines and Their Metal Complexes as Potential Anticancer Drugs.

Irina Kuznetcova, Marija Ostojić, Nevenka Gligorijević, Sandra Aranđelović, Vladimir B Arion

Abstract read
In one paragraph

Article in Inorganic chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Irina KuznetcovaInstitute of Inorganic Chemistry of the University of Vienna, Währinger Strasse 42, 1090 Vienna, Austria.ORCID 0000-0002-7425-3700
Marija OstojićDepartment of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia.
Nevenka GligorijevićDepartment of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia.
Sandra AranđelovićDepartment of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia.
Vladimir B ArionInstitute of Inorganic Chemistry of the University of Vienna, Währinger Strasse 42, 1090 Vienna, Austria.ORCID 0000-0002-1895-6460

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The search for new scaffolds of medicinal significance combined with molecular shape enhances their innovative potential and continues to attract the attention of researchers. Herein, we report the synthesis, spectroscopic characterization (

Indexed as

Antineoplastic AgentsColonic NeoplasmsCoordination ComplexesHeterocyclic CompoundsCell Line, TumorCell ProliferationCisplatinCopperGlycogen Synthase Kinase 3 betaHumansAntineoplastic AgentsCisplatinCoordination ComplexesCopperGlycogen Synthase Kinase 3 betaHeterocyclic Compounds

Identifiers

PMID36473464
PMCPMC9768754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.